Live Breaking News & Updates on Presenting Author|Page 4

Stay updated with breaking news from Presenting author. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Iterum Therapeutics Presented Data at the 32nd European Congress of Clinical Microbiology and Infectious Diseases

Iterum Therapeutics Presented Data at the 32nd European Congress of Clinical Microbiology and Infectious Diseases
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United States , Sulopenem Etzadroxil Probenecid , Exchange Commission , Surveillance Program , European Congress , Clinical Microbiology , Infectious Diseases , Vitro Activity , Steven Aroninposter Session , Intravenous Sulopenem Followed , Oral Sulopenem , Probenecid Versus Intravenous Ertapenem Followed , Oral Ciprofloxacin , Complicated Intra Abdominal Infections , Presenting Author , Iterum Therapeutics , Qualified Infectious Disease Product , Fast Track , Nasdaq Stock Market , Annual Report , Judy Matthewschief Financial Officer ,

Spero Therapeutics to Present Data at the 32nd European Congress of Clinical Microbiology and ...

CAMBRIDGE, Mass., April 21, 2022 (GLOBE NEWSWIRE) Spero Therapeutics, Inc. (Nasdaq: SPRO) today announced two oral presentations and four poster presentations at the 32nd European Congress of Clinical Microbiology ....

United States , United Kingdom , Jacqueline Pomfret Kirby , Keith Rodvold , Tsegaye Sewunet , Pharmd University Of Illinois Chicago , Tebipenem Hbr Research Support , Phd Karolinska Institute , Spero Therapeutics Inc , European Congress , Biomedical Advanced Research , Human Services , Us Department Of Health , Drug Administration , Development Authority , Program Committee , Exchange Commission , Office Of The , Corporate Affairs , Clinical Microbiology , Infectious Diseases , Presenting Author , Illinois Chicago , Karolinska Institute , Key Publications , Spero Therapeutics ,

New Two-Year Data Showed Bimekizumab Maintained High Levels of Skin Clearance in Patients with Moderate to Severe Plaque Psoriasis

New Two-Year Data Showed Bimekizumab Maintained High Levels of Skin Clearance in Patients with Moderate to Severe Plaque Psoriasis
prnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.com Daily Mail and Mail on Sunday newspapers.

United States , Bruxelles Capitale , Emmanuel Caeymaex , Eimear Obrien , Mark Lebwohl , J Clin Dermatol , Antje Witte , Laurent Schots , Allyson Funk , Immunology Solutions , Ericj Waldman Department Of Dermatology , Us Communications , Brand Communications , European Commission , Drug Administration , International Federation Of Psoriasis Associations , Icahn School Of Medicine At Mount Sinai , American Academy Of Dermatology , Corporate Communications , National Psoriasis Foundation , Summer Meeting , Clinical Therapeutics , Icahn School , Mount Sinai , Presenting Author , Executive Vice President ,

New Two-Year Data Showed Bimekizumab Maintained High Levels of Skin Clearance in Patients with Moderate to Severe Plaque Psoriasis

New Two-Year Data Showed Bimekizumab Maintained High Levels of Skin Clearance in Patients with Moderate to Severe Plaque Psoriasis
apnews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from apnews.com Daily Mail and Mail on Sunday newspapers.

United States , Bruxelles Capitale , Emmanuel Caeymaex , Eimear Obrien , Mark Lebwohl , J Clin Dermatol , Antje Witte , Laurent Schots , Allyson Funk , Immunology Solutions , Ericj Waldman Department Of Dermatology , Us Communications , Brand Communications , European Commission , Drug Administration , International Federation Of Psoriasis Associations , Icahn School Of Medicine At Mount Sinai , American Academy Of Dermatology , Corporate Communications , National Psoriasis Foundation , Summer Meeting , Clinical Therapeutics , Icahn School , Mount Sinai , Presenting Author , Executive Vice President ,

New Two-Year Data Showed Bimekizumab Maintained High Levels of Skin Clearance in Patients with Moderate to Severe Plaque Psoriasis

New Two-Year Data Showed Bimekizumab Maintained High Levels of Skin Clearance in Patients with Moderate to Severe Plaque Psoriasis
prnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.com Daily Mail and Mail on Sunday newspapers.

United States , Bruxelles Capitale , Emmanuel Caeymaex , Eimear Obrien , Mark Lebwohl , J Clin Dermatol , Antje Witte , Laurent Schots , Allyson Funk , Immunology Solutions , Ericj Waldman Department Of Dermatology , Us Communications , Brand Communications , European Commission , Drug Administration , International Federation Of Psoriasis Associations , Icahn School Of Medicine At Mount Sinai , American Academy Of Dermatology , Corporate Communications , National Psoriasis Foundation , Summer Meeting , Clinical Therapeutics , Icahn School , Mount Sinai , Presenting Author , Executive Vice President ,